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RELATION OF CHEMICAL STRUCTURE TO
FUNGISTATIC ACTIVITY*
HERMAN I. CHINN, Pu.D., tOLAND B. MITCHELL, PH.D. AND
ANNA C. ARNOLD, B.A.
Many workers have shown that the introduction of a halogen into the nucleus
of a phenolic compound increases its bactericidal and fungicidal potency. Klar-
mann and co-workers (1, 2) demonstrated that halogenation in para position to
the hydroxyl group was more effective than the ortho-substitution and that intro-
duction of alkyl groups further increased the potency of the compounds. The
relative effect of bromination and chlorination has been a controversial point.
The monobromo derivatives were less effective than the chlorinated compounds
against typhoid and paradysentery organisms but more so against staphylococcus
and streptococcus (1). Marsh et al. (3) found that brominated bisphenols were
less fungistatic than the corresponding chlorinated compounds. Other investi-
gators (4) claimed that bromine substitution produced a more potent bactericide
and fungicide than did chlorine while iodine gave an even more effective prepa-
ration. The most promising of a series of halogenated salicylaldehydes against
Trichophyton mentagrophytes was the dibromo derivative (5). Fluoro-phenol,
however, differed but little in its germicidal action from phenol itself (6).
The recent demonstration that certain antihistaminic drugs have significant
fungistatic action (7) stimulated interest in this pharmacologic group. It was
noted that members of this group containing chlorine were more active than
their parent compound (8). These compounds were nonpheñolic in nature, thus
differing from those already reported. It was thought important to extend this
series and to include other halogenated derivatives as well as chlorine. Since all
compounds tested containing the phenothiazine nucleus inhibited fungous
growth, additional compounds of this type were also included in the study.
MATERIALS AND METHODS
The structures of the compounds testedt are shown in Table I. Since many of
these compounds are not available commercially and have no common name,
reference will be made to them by our own number, as indicated in the first
column. A few fungistats were tested which were neither antihistaminic, their
halogenated derivatives, nor phenothiazine preparations. These were included
for comparative purposes. The test cultures employed were Trichophyton menta-
grophites, Microsporum canis, Monosporium apiospermum, Sporotrichum Schenkii,
Phialophora verrucosa, and Candida albicans. The method of testing for fungi-
static activity was the same as described in our previous report (8). It consisted
essentially of determining the zones of partial and complete inhibition of fungal
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growth surrounding a sensitivity paper disc impregnated with various concen-
trations of the test compound.
All compounds were dissolved in 70 per cent alcohol and made up to the appro-
priate concentration (0.0001 to 0.1 M).
A limited series of these compounds was also tested in the same manner against
Coccidioides immitis. This culture was chosen as a typical example of a systemic
mycotic infecting agent.
TABLE 1— STRUCTURE OF COMPOUNDS STUDIED
RESULTS AND DISCUSSION
The effectiveness in completely inhibiting growth of the various fungi is sum-
marized in Table II, and the extent of partial inhibition similarly listed in Table
III. Members of each family of compounds are grouped in Tables II and III to
facilitate comparison. The halogenated series are not as complete as would be
desirable since relatively few derivatives of the antihistaminics were available.
This is especially true of the fluorinated and iodinated derivatives. Pyribenzamine
is the only antihistamine for which either derivative could be obtained. The
fluorine derivative shows little superiority over the parent compound. Partial
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CHEMICAL NAME MANUFACTURER RI— RU— N— —R3- —X —R4 —R5 SALT FORM
PYRIBENZAMINE CIBA CR,— CR,— F4— CR8—CjM— N( *M- HYUROCRLORIQE
CI 216—109—215 AMERICAN CYANAMID CII,— CR,— N— —CR,—CH,— —NC -C66.—I
——Br IIYDROCHI.ORIDE
Cl 216-413—169 AMERICAN CYANAMID CR,— CR,— CM— —CR,—062— 6< H ——8r MYDROCRIORIDE
CI 216—114—116 AMERICAN CYANAMID CR,— CH. CN— CII6CR, —NC CR26F C HVOROCHLORCE
CI 216—118—66 AMERICAN CYANAM0 CA,— CR,— CN BC CR.-I
-'a)' HYDROCHLORIDE
NEORETRAMINE NEPERA CR.— CR.— CS —CRZCRZ —BC
-CR,-l—0cH RHDROCRLO6IDE
1158 NEPERA CR,— CR, — CM CUCK.—NIZ
-CR--00T
—c—CI HYDROCHLORIDE
1157 NEPERA CR, CII, — CM— —CR, —CR6— —NC -CHr --CI HYDROCHLORIDE
1166 NEPERA CR.- CR.— CR —NC -CHr -<) HYDROCHLORIDE
HISTADYL LILLY CR, — CR, — CN —CM, —clA——NC
—Q -CH,- MYOROCIILORIDE
TAGATIEN LEDERLE CR, CII, — )N —CR6—C
-CZ -CHZç-CI CITRATE
CI 216—86—184 AMERICAN CYANOMID CII,— CIIR— CN— —CH,—CR,— —NC
— -CH,--O METHI000E
BROMOTREN LEDERLE CR6— CM, CN —CR,CR, •-NC •' -CYZ-çI-86 MYDROCRLORIDE
ISORROMOTIIEN AMERICAS CYANAMID CR.— CR.— CN .-CR,-CH. N(
-Ca, .CMçft HYDROCHLORIDE
PORALMIN EATON CR,— CR,— CS— —CR6-CR,— —N(
— CV8 FIMARA1E
RIRO EATON CR,— CR6— CN —CR1—CR,- 5(
-CR6-V-lA FO6ZARATE
BENADRYL PARKE—DAVIS CM,— CR,— CN —CR6—CM,— •4:Z RYDVOCMLOR1DE
PARRE—DAVIS CR,— CM,— CN— —CRZCR, —ZC —CI HYDROCHlORIDE
PARKE—DAVIS CR,— CR,— )N— —CR6—SI,— ,C1 -CI VYOROCIIIOHIDE
AM800RYL PARKE—DAVIS CM,— CR,— CS— -CR6—CA,—
—< ——Br RYDROCRZORIDE
DECAPRYN MERRELL CR,— CR,— CM— -CR6-CR,— —0—CECIl, SACCINATE
2788—255
3SRR—66
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inhibition of M. canis is affected at a slightly lower concentration, but all other
fungi respond identically to either Pyribenzamine or its fluorine derivative.
Substitutions of iodine, however, significantly improve the fungistatic action.
Thus, Pyribenzamine inhibits none of the fungi completely even at 0.1 M con-
centrations and gives partial inhibition oniy to T. mentagrophytes and M. canis.
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TABLE 1 (CON'T) STRUCTURE OF COMPOUNDS STUDIED
* Exact positioning of CII, is questionable. Lergigan and Phenergan may be identical.
The iodine-containing preparation, on the other hand, inhibits all cultures com-
pletely except P. verrucosa which it inhibits partially at 0.05 M concentration.
Approximately the same inhibition is obtained with the 2 bromine derivatives
(2 and 3) and with a chlorinated derivative reported previously.
In practically all cases, the bromine or chlorine-containing compounds average
a greater activity than the parent compound. No distinction can be made on the
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CHEMICAL. &JAME MANUFACTURER R1— R2- N- P3— —X( —R4 —H3 SALT FORM
ASTEROL C2R. C.H. )N-. CIII CH. CH, CR, HYDROCHLORIDE
LISERGUN RRONE—POULENC coo— CR— >L —CR—CH,— HYDROCHLORIDE
LERGIGAN
•
RECIP CR,— CII,— >2-
—c
'
HYDROCHLORIDE
PRENEROAN WYETH CR,— CR,—
.N CR,I
—CII — CR,- HYDROCHLORIDE
DIPARCOL RIlONE—FOULENC C,H,— C,H,— >1— —CR, .CI1,- HYDROCHLORIDE
MEILTEROAN RIIONC-POULENC cu,— ,—
CI
1M
CH—CR,—
MCtHY. SULFATE
45994 C,R,— C,Y,— 2N
—CR—CC-
HYDROCHLORIDE
ASTRA CII,— CR4
CR,—CH,
—CRLR,—C- , HYDROCHLORIDE
47—03 DIIRROUGOS—WELLCOSIE CR,.N('1)N_ , —. RYOROC9LOI1IDE
PCRUZIL bURYOUQYC—WCLL000E C0,—N(CY,—CII, ' 'GI IIYOROCIILOYIDE
40—ICC 00000IICRS-WELLCLIRLE , -CL HIOROCIILDIIIDE
48—239 OUYROIIGYS—WELLCYRE CLI,_N('"' N—
CR,—Ti-I I,—G 2—CI —CI 4VD800LILORIDE
DIPYENYLPIROLINE NATIOIIUL OIL CR,_N('IR_ I, — HVDROCHLORIIA
1718 CH,_N(C;H9_ CITRATE
904 NATONAL CH,_N('H_ I, -> CITR8TE
5082 UNION CR181008 BEDOE c0..CHN(C_I' N 1, —<o ——cI HYDROCHLORIDE
820114 GEIGY
021772 GEIGY42
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TABLE II
Minimal molar concentration required to inhibit fungous growth completely
NO. NAME T MENTA-OROPHYTES N. CANIS
N APIO-
SPERNUM
S
SCEENEII
PN
VERRUCOSA
C
ALBICANS
1
2
3
4
5
Pyribenzamine
Cl 216-109-215A
C1216-113-169
01216-114-116
01216-118-66
0
Br
Br
F
I
>0.1
0.05
>0.1
>0.1
0.05
>0.1
0.05
>0.1
>0.1
0.05
>0.1
0.1
>0.1
>0.1
0.1
>0.1
0.075
>0.1
>0.1
0.05
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
0.075
>0.1
>0.1
0.05
6
7
8
9
Neohetramine
1158
1157
1168
0
Cl
Cl
Cl
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
10
11
12
13
14
Histadyl
Tagathen
01216-86-184
Bromothen
Isobromothen
0
Cl
Cl
Br
Br
>0.1
>0.1
>0.1
0.075
0.1
>0.1
>0.1
0.075
0.075
0.075
>0.1
>0.1
>0.1
0.1
>0.1
>0.1
>0.1
>0.1.
0.05
>0.1
>0.1
0.075
0.05
>0.1
>0.1
>0.1
0.075
0.075
0.075
>0.1
15
16
Foralmin
F 180
0
Br
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
17
18
19
20
Benadryl
—
—
Ambodryl
0
C1(2)
C1(2)
Br
>0.1
0.025
0.025
0.05
>0.1
0.025
0.05
0.05
>0.1
0.05
0.05
0.1
>0.1
0.025
0.025
0.075
>0.1
0.05
0.075
0.075
>0.1
0.025
0.025
0.075
21
22
23
24
Decapryn
278 R-255
358 R-66
354R 285a 163102
0
Cl
Cl
0
>0.1
>0.1
>0.1
0.0075
>0.1
>0.1
>0.1
0.025
>0.1
>0.1
>0.1
0.075
>0.1
>0.1
>0.1
0.05
>0.1
>0.1
>0.1
0.1
>0.1
>0.1
>0.1
0.1
25 Asterol 0 0.001 0.005 >0.1 >0.1 >0.1 >0.1
26
27
28
29
30
31
32
Lisergan
Lergigan
Phenergan
Diparcol
Multergan
—
—
0
0
0
0
0
0
0
0.05
0.025
0.05
0.05
>0.1
>0.1
0.025
0.075
0.05
0.05
0.075
>0.1
>0.1
0.025
0.1
0.05
0.05
0.075
0.1
>0.1
0.075
0.075
0.05
0.075
>0.1
0.05
>0.1
0.025
0.075
0.075
0.075
0.075
>0.1
0.05
0.025
0.05
0.05
0.05
0.05
0.075
>0.1
>0.1
33
34
35
36
47-83
Perazil
4S-166
48-239
0
Cl
01(2)
C1(2)
>0.1
0.01
0.025
0.025
>0.1
0.025
0.01
0.01
>0.1
0.075
0.025
0.025
>0.1
0.05
0.05
0.05
>0.1
0.05
0.025
0.025
>0.1
0.05
0.025
0.05
37
38
39
Diphenylpyraline
171B
190A
0
Cl
Br
0.075
0.075
0.075
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
0.075
0.05
0.075
40 Postafene Cl >0.1 >0.1 >0.1 >0.1 0.075 >0.1
41
42
G20714
G21772
00 0.00750.0005 0.005<0.0001 0.0250.05 0.0250.025 0.010.01 0.0075<0.0001
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TABLE III
Minimal molar concentration reouired to inhibit funaou8 growth partially
NO NAME CF
PEESENT
T. MENTA-
OROPUITES u CANIS
M. APIO-
SPERMUIL
S.
SCHEMEIX
PM
VEREUCOSA
C.
ALBICARS
1
2
3
4
5
Pyribenzamine
Cl 216-109-215A
Cl 216—113—169
C1216—114—116
Cl 216-118.66
0
Br
Br
F
I
0.025
0.005
0.075
0.025
0.005
0.025
0.025
0.075
0.01
0.005
>0.1
0.05
>0.1
>0.1
0.05
>0.1
0.05
>0.1
>0.1
0.05
>0.1
0.05
0.075
>0.1
0.05
>0.1
0.05
>0.1
>0.1
0.05
6
7
8
9
Neohetramine
1158
1157
1168
0
Cl
Cl
Cl
0.075
0.0075
0.0075
0.05
0.075
0.0075
0.0075
0.075
>0.1
0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
0.1
>0.1
>0.1
>0.1
>0.1
>0.1
>0.1
10
11
12
13
14
Histadyl
Tagathen
Cl 216-86-184
Bromothen
Isobromothen
0
Cl
Cl
Br
Br
0.025
0.005
>0.1
0.005
0.01
0.025
0.005
0.025
0.005
0.0075
>0.1
0.075
0.075
0.05
0.05
>0.1
>0.1
0.025
0.05
0.075
>0.1
0.025
0.05
0.075
0.075
>0.1
0.05
0.025
0.05
0.1
15
16
Foralmin
F180
0
Br
0.075
0.01
>0.1
0.01
>0.1
0.1
>0.1
>0.1
0.075
0.05
>0.1
>0.1
17
18
19
20
Benadryl
—
—
Ambodryl
0
C1(2)
C1(2)
Br
0.01
0.001
0.0025
0.0075
0.01
0.0025
0.0025
0.0025
>0.1
0.025
0.05
0.075
>0.1
0.025
0.01
0.05
>0.1
0.025
0.05
0.05
>0.1
0.025
0.025
0.05
21
22
23
24
Decapryn
278R-255
358 R-66
354R 285a 163102
0
CI
Cl
0
0.1
0.05
0.05
0.001
>0.1
0.025
0.025
0.005
>0.1
>0.1
>0.1
0.075
>0.1
>0.1
>0.1
0.05
>0.1
>0.1
>0.1
0.05
>0.1
>0.1
>0.1
0.05
25 Asterol 0 0.0001 0.001 0.025 >0.1 0.075 0.1
26
27
28
29
30
31
32
Lisergan
Lergigan
Phernergan.
Diparcol
Multergan
—
—
0
0
0
0
0
00
0.005
0.005
0.025
0.0025
0.1
0.025
0.025
0.005
0.01
0.005
0.0075
0.1
0.01
0.005
0.075
0.05
0.05
0.05
0.075
>0.1
0.0075
0.05
0.05
0.05
>0.1
0.05
>0.1
0.025
0.025
0.05
0.05
0.05
>0.1
0.025
0.0075
0.05
0.025
0.05
0.05
0.05
>0.1
>0.1
33
34
35
36
47-83
Perazil
48-166
48-239
0
Cl
Cl(2)
Cl(2)
0.025
0.005
0.0025
0.0025
0.01
0.0025
0.0025
0.005
0.1
0.05
0.025
0.025
>0.1
0.025
0.025
0.025
0.05
0.01
0.01
0.0075
>0.1
0.05
0.025
0.025
37
38
39
Diphenylpyraline
171B
190A
0
Cl
Br
0.01
0.0025
0.0025
0.0075
0.005
0.0025
0.1
>0.1
0.1
0.075
>0.1
>0.1
0.075
0.05
0.05
0.075
0.05
0.075
40 Postafene CI >0.1 >0.1 >0.1 >0.1 0.05 0.05
41
42
G20714
G21772
0
0
0.0075
0.0005
0.005
<0.0001
0.005
0.01
0.001 0.01 0.0025
0.0025 0.0025 <0.0001
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basis of the present data between chlorine or bromine. The only preparations
which are less active for any fungus than the corresponding non-halogenated
compounds are numbers 3, 12, 38, and 39. Compounds 3 and 12 cannot strictly
be compared with the non-halogenated compounds since they differ slightly in
other respects as well as the possession of a halogen. Compound 3 differs from
Pyribenzamine in the absence of a benzyl group and compound 12 has a different
salt form. Diphenylpyraline shows a slightly greater activity against S. Schenkii
than either the chlorinated or brominated compound (38 and 39). It is also
slightly more effective against M. apiospermum than compound 38. These differ-
ences are questionable since they represent only a single dilution. Furthermore,
against the remaining fungi the halogenated compounds are more effective.
Except for the questionable exceptions just discussed, in no case is the fungi-
static activity of the non-halogenated compound higher than the halogen
derivatives. In many instances the superiority of the latter compounds is espe-
cially striking. Thus, Benadryl is unable to inhibit any of the 6 fungi completely
at a concentration of 0.1 M and only 2 of the 6 even partially at this concentra-
tion. Each of the halogenated derivatives, however (18, 19, 20), gives complete
fungistasis of every fungus in these concentrations and partial inhibition at levels
as low as 0.001 M. Similarly, brominated Pyribenzamine (2) inhibits completely
all fungi at 0.1 M concentrations except P. verrucosa whereas Pyribenzamine
itself can inhibit none at this concentration.
The data suggest that the introduction of 2 chlorine atoms into the molecule
is more effective than a single chlorine. Compounds 35 and 36, containing 2
chiorines, are slightly more active than compound 34 which contains only 1,
which, in turn, is more active than number 33 which contains none.
As in the previous report, the phenothiazine derivatives show good fungistatic
activity. Lisergan, Phenergan,* and Lergigan* inhibit all fungi completely at
concentrations of 0.1 M or less. The remaining compounds have fair activity but
fail to inhibit at least one of the fungi employed.
The greatest activity over the widest spectrum is afforded by the phenan-
throline compounds (41 and 42) which inhibit all fungi at concentrations from
<0.0001 to 0.05 M.
The importance of obtaining an effective agent against systemic mycotic infec-
tions prompted the testing of the active agents listed in Tables II and III
against Coccidioides immitis. The results are shown in Table IV. The zone of
inhibition was read after 10 days' growth. Inhibition roughly parallels that ob-
served with other fungi, although many differences are apparent. The most strik-
ing inhibition is given by the commercial fungistats (41, 42, and 24). To our
knowledge, no previous report of their activity against Coccidioides immitis has
been made. Five of the 15 compounds showing unequivocal inhibition are pheno-
thiazine derivatives. Halogenated derivatives again show greater activity than
their non-halogenated parents. Two of the most active compounds (35 and 36)
each contain two chlorine atoms. Perazil (34) containing one chlorine atom gave
significant inhibition, while 33 with no chlorine was completely ineffective. Simi-
* Recent data (9) suggest that these 2 compounds may be identical.
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larly, compounds 18 and 19, the dichiorinated derivatives of Benadryl, gave ex-
cellent inhibition; Ambodryl (20), the mono bromo derivative, had questionable
activity and Benadryl itself has little effect.
There seems little doubt that chlorination, bromination, and probably iodina-
tion, increase the activity against most fungi. Also, the substitution of a second
chlorine apparently produces still more active compounds. It would be highly
TABLE IV
Effectiveness of various compounds (O.1M) in inhibiting growth of coccidioides immitis
NO. NAME HALOGENSPRESENT
DIAMETER OE ZONES INHIBITION
Complete Partial
cm. cm.
41 Geigy 20704 0 6.2 8.0
42 Geigy 21772 0 5.4 6.8
24 Merrell 354R-285a 063002 0 4.2 7.0
27 Lergigan 0 3.4 Entire plate
35 Burroughs Welicome 48-166 CI(2) 3.4 6.3
36 Burroughs Welicome 48-239 Cl (2) 3.4 5.8
32 0 3.4 4.4
26 Lisergan 0 3.0 8.4
18 Cl(2) 2.9 7.4
34 Perazil Cl 2.8 7.0
19 Cl(2) 2.8 5.5
29 Diparcol 0 2.3 Entire plate
28 Phenergan 0 2.0 8.4
5 American Cyanasnide C1-216-118-66 I 1.8 7.2
2 American Cyanamide Cl-216-109-215A Br 1.5 6.4
25 Asterol 0 0 Entire plate
11 Tagathen Cl 0 7.4
20 Ambodryl Br 0 7.4
13 Bromothen Br 0 7.0
14 Isobromothen Br 0 7.0
7 Nepera 1158 Cl 0 7.0
8 Nepera 1157 Cl 0 5.7
37 Diphenylpyraline 0 0 5.5
4 American Cyanamide 216-114-116 F 0 4.7
17 Benadryl 0 0 4.3
16 Eaton F 180 Br 0 4.2
38 Nopco 171B Cl 0 4.0
33 Burroughs Weilcome 47-83 0 0 3.5
31 0 0 0
desirable to study the anti-fungus spectrum of a large number of such compounds
and to test the most promising in vivo, especially against systemic infections.
Further screening of additional preparations is planned, as are the indicated
clinical studies.
SUMMARY
A total of 42 compounds were tested against Trichophyton mentagrophytes,
Microsporum canis, Monosporium apiospermum, Phialophora verrucosa, Sporo-
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richum Schenkii, and Candida albicans. Their relative effectiveness against each
fungus is tabulated. The most effective of these compounds were tested against
Coccidioides immitis.
Chlorination and bromination increase the fungistatic activity against most
fungi. In the only instance tested, iodination increased the effectiveness but
fluorination did not. The substitution of 2 chlorine atoms seemed to increase
activity still further.
Additional phenothiazine derivatives were tested and were found active in
most cases.
The most active fungistats against Coccidioides immitis were 1, 10 phenanthro-
line; 2, 9 dimethyl 1, 10 phenanthroline; and beta diethylamino ethyl 1 methyl
3 isopropyl cyclopentane-carboxylate hydrochloride.
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